Cranberry, Vitamin C and Glutamine. If you have trouble viewing this email, view it online. connect with us     A woody perennial vine, cranberry is prevalent in the northeastern part of North America. The berries were used by Native Americans to treat fevers, wounds, swelling, blood disorders and seasickness. Cranberry is used in beverages and food, and the supplemental form, for urinary tract infections. Preclinical studies have shown that cranberry constituents and juice extracts have antimicrobial, anti‑inflammatory, antioxidant, and anti‑adherence effects. Cranberry was reported useful in clinical trials for treating urinary tract infections (UTIs) in adults and in children; in preventing cystitis and in reducing the risk of UTIs in prostate cancer patients undergoing radiation therapy. But conflicting findings preclude recommending cranberry for preventing UTIs. Other trials found that regular consumption of cranberry juice suppresses H. pylori infection, a major factor in peptic ulcer disease, which may lead to gastric cancer; and improves cardiovascular disease risk factors in diabetic men. Cranberry proanthocyanidins and its extracts also demonstrated anti‑proliferative effects against cancers of esophagus, stomach, colon, bladder, prostate, glioblastoma and lymphoma. Due to high amounts of oxalate (a common component of kidney stones) in cranberry juice, consumption should be limited in patients with a history of nephrolithiasis. Learn More     Personalize Your Updates Manage your preferences, and we will customize your updates based on your interests.   Go to my preferences   Essential Updates Vitamin C: A systematic review suggests that perioperative administration of vitamin C helps improve clinical and economic outcomes in patients undergoing cardiac surgery. Learn more Glutamine: A randomized study of patients with oropharynx and larynx carcinoma reported benefits of glutamine supplementation in decreasing chemo‑radiotherapy‑induced oral mucositis and dysphagia. Learn more   Integrative Medicine Therapies Fundamentals of Integrative Oncology Online Education Course People with cancer are looking for guidance in using integrative therapies alongside their cancer care to improve cancer‑related side effects, such as chronic pain, insomnia, nausea and vomiting, and stress. Developed by Memorial Sloan Kettering’s experts in the field of integrative oncology, this multidisciplinary online course provides clinicians with the essential guidelines for making safe and personalized recommendations to their patients. Study the current state of the evidence and the physiological mechanisms of action of non‑pharmacologic approaches, including mind‑body therapies, acupuncture, exercise, and herbal medicine. Learn How To: Define integrative oncology and its role in cancer care. Enhance proficiency in communicating with patients and caregivers about evidence‑based uses of integrative modalities. Identify safe and supportive integrative treatments for specific cancer‑related symptoms and side effects. Understand common and preventable herb‑drug interactions. Optimize evidence‑based practice in lifestyle medicine and side effect management across the cancer care continuum. Target Audience: Clinicians Course Fee: $125 – MD, DO, PhD, PSyD $85 – Advanced Practice Providers, Residents, Fellows $65 – Nurses, Social Workers, Other Healthcare Providers The Integrative Medicine Service offers a variety of therapies, classes, and workshops for patients and survivors to help manage symptoms associated with cancer and its treatments, and to improve physical and psychological well‑being.   Click Here to Register and Learn More     Take Note Of: Antineoplastons A controversial alternative cancer treatment developed by Stanislaw Burzynski, antineoplastons refer to a mixture of peptides, amino acids and other compounds that were first isolated from human urine and blood. They are thought to be the natural biochemical defense system that protects the body from disease, including cancer. The U.S. National Cancer Institute sponsored clinical trials in 1993 to investigate the anticancer potential of antineoplastons in patients with brain tumors. The studies were closed two years later as poor patient accrual precluded conclusions about the efficacy of the treatment. Antineoplastons are not approved by the U.S. FDA for the prevention or treatment of any disease. Adverse reactions following their use include confusion, sleepiness, exacerbation of underlying seizures, headache, vomiting, and fatigue. Patients should be informed that antineoplastons are not substitutes for standard cancer treatments. Learn More   Share with a Friend Click the link below to share this email with others who might be interested. Invite friends Contact Us We welcome your feedback, and encourage you to send us a message at: aboutherbs@mskcc.org To Make An Appointment: Integrative Medicine Service: 646-888-0800 MSKCC Main Hospital: 800-525-2225 Find an MSK location   ©2019 Memorial Sloan Kettering Cancer Center 1275 York Ave., New York, NY 10065 US November 2019   To ensure you continue to receive emails from About Herbs, add us to your address book or safe list. To unsubscribe, click here. This message was sent to newsletter@newslettercollector.com. To manage your preferences, click here. You are receiving this email because you subscribed to e-newsletters from About Herbs. To forward this email click here.